Delivery Order SPE2DB20D3104-SPE2DB25FV5G5
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine DR 1.2 GM Tablet 120S. The $1,541.04 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award, SPE2DB20D1004|SPE2DB24FG2B6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,160.52 Firm Fixed Price Delivery Order is for the provision of Mesalamine DR 1.2 GM Tablets in quantities of 120. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,481.85, is for the delivery of Mesalamine DR 1.2 GM Tablets in quantities of 120. The contract has a period of performance through March 5, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, SPE2DB22D3004|SPE2DB24FQJ48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,561.00, is for the delivery of 180 tablets of 800 mg mesalamine delayed-release medication. The contract is a Firm Fixed Price delivery order with a completion date of May 15, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of 4,561,559,448 tablets of Mesalamine DR 1.2 GM. The total ceiling value of the delivery order is $3,846.35, with a firm fixed price. The contract has an ultimate completion date of July 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This federal contract award, with an ID of SPE2DB20D1004|SPE2DB25FNEWX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product, with a ceiling value of $3,126.95 and a completion date of February 13, 2025. This is a firm fixed-price delivery order contract. The contract does not have a set-aside designation,...
This federal contract award, with ID SPE2DB22D1202|SPE2DB23FHMS9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Mesalamine 800 mg delayed-release tablets, with a ceiling value of $4,750.03 and a completion date of May 1, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award SPE2DB22D3301|SPE2DB24FX4QH was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,078.47 firm fixed-price delivery order is for the supply of 4562654942 - Mesalamine DR 1.2 GM Tablet 120S, a medication used to treat certain gastrointestinal conditions. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, with ID SPE2DX15D3404|SPE2DX24F0ZCQ, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain division to the prime contractor Amerisourcebergen Drug Corp. The $12,756.40 firm fixed-price delivery order is for the procurement of 4,563,239,385 units of the drug Mesalamine DR 1.2 GM Tablet in 120-count packages. The contract has an ultimate completion date of January 5, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,368.24, is for the delivery of 120 units of Mesalamine DR 1.2 GM Tablets. This is a firm fixed-price delivery order contract with a completion date of May 5, 2023. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery...